A Study of WJ05129 in Advanced Malignant Solid Tumors

Clinical trial NCT05326035 · TERMINATED

Trial details

NCT number: NCT05326035
Sponsor: Suzhou Junjing BioSciences Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Malignant Solid Tumors

Start date: 2022-04-19
Primary completion: 2023-12-26
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.